113 related articles for article (PubMed ID: 29562996)
1. Factors associated with hospitalisation costs in patients with chronic obstructive pulmonary disease.
Li F; Sun Z; Li H; Yang T; Shi Z
Int J Tuberc Lung Dis; 2018 Apr; 22(4):458-463. PubMed ID: 29562996
[TBL] [Abstract][Full Text] [Related]
2. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
3. Factors contributing to high-cost hospital care for patients with COPD.
Mulpuru S; McKay J; Ronksley PE; Thavorn K; Kobewka DM; Forster AJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():989-995. PubMed ID: 28392683
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations].
Targowski T; Jahnz-Rózyk K; From S; Płusa T
Pneumonol Alergol Pol; 2005; 73(1):32-5. PubMed ID: 16539181
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function.
Lim JU; Kim K; Kim SH; Lee MG; Lee SY; Yoo KH; Lee SH; Jung KS; Rhee CK; Hwang YI
Int J Chron Obstruct Pulmon Dis; 2017; 12():2711-2721. PubMed ID: 28979113
[TBL] [Abstract][Full Text] [Related]
6. Rising total costs and mortality rates associated with admissions due to COPD exacerbations.
Molinari N; Chanez P; Roche N; Ahmed E; Vachier I; Bourdin A
Respir Res; 2016 Nov; 17(1):149. PubMed ID: 27842545
[TBL] [Abstract][Full Text] [Related]
7. Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
Friedman M; Menjoge SS; Anton SF; Kesten S
Pharmacoeconomics; 2004; 22(11):741-9. PubMed ID: 15250751
[TBL] [Abstract][Full Text] [Related]
8. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010.
de Miguel-Díez J; Jiménez-García R; Hernández-Barrera V; Puente-Maestu L; Rodríguez-Rodríguez P; López de Andrés A; Carrasco-Garrido P
Respir Med; 2013 May; 107(5):717-23. PubMed ID: 23421969
[TBL] [Abstract][Full Text] [Related]
9. Clinical factors and comorbidities affecting the cost of hospital-treated COPD.
Deniz S; Şengül A; Aydemir Y; Çeldir Emre J; Özhan MH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3023-3030. PubMed ID: 27980399
[TBL] [Abstract][Full Text] [Related]
10. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data.
Li M; Wang F; Chen R; Liang Z; Zhou Y; Yang Y; Chen S; Ung COL; Hu H
Int J Chron Obstruct Pulmon Dis; 2018; 13():3349-3357. PubMed ID: 30349238
[TBL] [Abstract][Full Text] [Related]
11. COPD: Does Inpatient Education Impact Hospital Costs and Length of Stay?
Hosseini HM; Pai DR; Ofak DR
Hosp Top; 2019; 97(4):165-175. PubMed ID: 31621519
[No Abstract] [Full Text] [Related]
12. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease.
Matkovic Z; Huerta A; Soler N; Domingo R; Gabarrús A; Torres A; Miravitlles M
Respiration; 2012; 84(1):17-26. PubMed ID: 22327370
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
Jahnz-Rózyk K; Targowski T; From S; Płusa T
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
[TBL] [Abstract][Full Text] [Related]
14. The burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in Canada.
Maleki-Yazdi MR; Kelly SM; Lam SY; Marin M; Barbeau M; Walker V
Can Respir J; 2012; 19(5):319-24. PubMed ID: 23061077
[TBL] [Abstract][Full Text] [Related]
15. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
Moll K; Sun SX; Ellis JJ; Howe A; Amin A
Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
[TBL] [Abstract][Full Text] [Related]
16. [Cost analysis in patients admitted with COPD in 2002].
Strâmbu I; Bucşa S; Nicolescu D; Dumitrescu C; Grigorescu B; Stoicescu IP
Pneumologia; 2004; 53(4):161-8. PubMed ID: 16106723
[TBL] [Abstract][Full Text] [Related]
17. Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation--the Italian SOS (Stratification Observational Study).
Lusuardi M; Blasi F; Terzano C; Cricelli C; Crispino N; Comarella L; De Benedetto F; Sanguinetti CM; Allegra L; Donner CF
Monaldi Arch Chest Dis; 2009 Dec; 71(4):153-60. PubMed ID: 20440919
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on health care utilization and hospital outcomes of severe acute exacerbation of chronic obstructive pulmonary disease managed by pulmonologists vs internists.
Pothirat C; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():759-66. PubMed ID: 25926727
[TBL] [Abstract][Full Text] [Related]
19. [Costs of hospitalisation for exacerbations of COPD in patients receiving domiciliary rehabilitation].
Romain D; Bernady A; Etchamendy E; Barokas T; Pignede P
Rev Mal Respir; 2011 Sep; 28(7):864-72. PubMed ID: 21943531
[TBL] [Abstract][Full Text] [Related]
20. Role of Anemia in Home Oxygen Therapy in Chronic Obstructive Pulmonary Disease Patients.
Copur AS; Fulambarker A; Molnar J; Nadeem R; McCormack C; Ganesh A; Kheir F; Hamon S
Am J Ther; 2015; 22(5):361-6. PubMed ID: 23567789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
